Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pro-NAC for Pediatric TBI
NCT01322009Phase 2Completed
- Sponsor
- University of Pittsburgh
- Start
- Mar 2011
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acetylcysteine, probenecid in traumatic brain injury (TBI), sponsored by University of Pittsburgh. Started Mar 2011; status: completed.
02
Drugs
acetylcysteineprobenecid
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT01322009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01322009.